集体诉讼案件核心指控 - 律师事务所针对LifeMD公司于2025年5月7日至8月5日期间涉嫌发布重大虚假或误导性陈述发起集体诉讼 [1] - 指控公司管理层在三个关键方面存在虚假陈述： materially overstated LifeMD's competitive position [1] - 指控公司 recklessly raised 2025 guidance without properly accounting for rising customer acquisition costs in RexMD segment and for obesity drugs including Wegovy and Zepbound [1] - 指控公司关于业务、运营和前景的陈述 materially false and misleading and/or lacked a reasonable basis at all relevant times [1] 案件程序细节 - 股东参与集体诉讼的登记截止日期为2025年10月25日 [2] - 股东登记后将通过 portfolio monitoring software 获得案件状态更新 [2] - 寻求成为 lead plaintiff 的截止日期为2025年10月25日 [2] 律师事务所背景 - The Gross Law Firm 是一家 nationally recognized class action law firm [3] - 该律所 mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices [3] - 律所致力于确保公司遵守 responsible business practices and engage in good corporate citizenship [3]